⌘K

Login Start Free

Home/Filings/4/0001144204-18-014484

4//SEC Filing

Olert David Lewis 4

Accession 0001144204-18-014484

CIK 0001551986other

View on SEC.gov Company Profile

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 9:59 PM ET

Size

4.8 KB

Accession

0001144204-18-014484

Insider Transaction Report

Form 4

Period: 2018-01-25

INNOVATE BIOPHARMACEUTICALS, INC.INNT

Olert David Lewis

CFO

Transactions

Award
Common Stock
2018-01-25+10,000→ 70,000 total

Footnotes (1)

[F1]Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.

Documents

1 file

4
tv488255_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INNOVATE BIOPHARMACEUTICALS, INC.

CIK 0001551986

Entity typeother

Related Parties

1

filerCIK 0001506072

Filing Metadata

Form type: 4
Filed: Mar 12, 8:00 PM ET
Accepted: Mar 13, 9:59 PM ET
Size: 4.8 KB

View on SEC.gov